GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » ROE % Adjusted to Book Value

BIOA (Bioage Labs) ROE % Adjusted to Book Value : -70.74% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs ROE % Adjusted to Book Value?

Bioage Labs's ROE % for the quarter that ended in Sep. 2024 was -160.57%. Bioage Labs's PB Ratio for the quarter that ended in Sep. 2024 was 2.27. Bioage Labs's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -70.74%.

Bioage Labs ROE % Adjusted to Book Value Historical Data

The historical data trend for Bioage Labs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs ROE % Adjusted to Book Value Chart

Bioage Labs Annual Data
Trend Dec22 Dec23
ROE % Adjusted to Book Value
- -

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -70.74

Competitive Comparison of Bioage Labs's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioage Labs's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bioage Labs's ROE % Adjusted to Book Value falls into.


Bioage Labs ROE % Adjusted to Book Value Calculation

Bioage Labs's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Bioage Labs's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-160.57% / 2.27
=-70.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Bioage Labs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
Traded in Other Exchanges
N/A
Address
1445A South 50th Street, Richmond, CA, USA, 94804
Website
https://www.bioagelabs.com
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.